Merck is well-stocked on Keytruda as pharma tariffs loom, CEO saysnews2025-04-24T19:12:24+00:00April 24th, 2025|Endpoints News|
Biosimilar launch challenges remain, report findsnews2025-04-24T19:01:09+00:00April 24th, 2025|Endpoints News|
Drugmakers prepare for manageable tariff hit to business, earningsnews2025-04-24T18:28:14+00:00April 24th, 2025|Endpoints News|
Cassidy urges major reforms to 340B drug discount programnews2025-04-24T18:16:58+00:00April 24th, 2025|Endpoints News|
Halozyme launches patent fight over Merck’s injectable Keytrudanews2025-04-24T16:58:38+00:00April 24th, 2025|Endpoints News|
Bristol Myers CEO signals dealmaking will be a top priority in 2025news2025-04-24T15:29:15+00:00April 24th, 2025|Endpoints News|
Bristol Myers Q1 earnings: Transition continues as drugmaker raises guidancenews2025-04-24T10:59:38+00:00April 24th, 2025|Endpoints News|
Thermo Fisher buckles up for US-China trade war, budgets $2B to ease impactnews2025-04-24T10:45:23+00:00April 24th, 2025|Endpoints News|
Roche takes steps to protect itself from tariffs, while Sanofi hangs backnews2025-04-24T10:35:48+00:00April 24th, 2025|Endpoints News|
Merck Q1 earnings: Gardasil sales hit by China market pressurenews2025-04-24T10:30:47+00:00April 24th, 2025|Endpoints News|
